| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |